Fibrovein® [Sodium tetradecyl sulfate]

Brand STD Pharmaceutical

All payments are SSL encrypted
Full Refund if you haven't received your order
International shipping to the USA, UK and Europe

Clinical Pharmacology

Fibrovein has a venosklerosiruyuschee effect. When in contact with the endothelium causes a rapid coagulation of its proteins.

Indications

Various forms of lower limb varicose veins, including intradermal varicose veins and telangiectasias.

Composition

1 ml of an aqueous solution contains sodium tetradecyl sulfate 3 mg.

Sodium tetradecyl sulfate is marketed under different brands and generic names, and comes in different dosage forms:

Brand name	Manufacturer	Country	Dosage form
Fibrovein	STD Pharmaceutical	UK	ampoules
Fibrovein	STD Pharmaceutical	UK	vials

No customer reviews for the moment.

Write your review

Dosage and Administration

Fibrovein administered IV, into the lumen of the isolated segment of the empty superficial vein with its immediate long-term compression (the imposition of a compression band). The dosage is determined depending on the size of the vein subjected to hardening; usual dose - 1 ml (not more) in one place. For Fibro-Wein 0.2% - the maximum single dose up to 10 ml. If necessary, additional injections are performed after a 2-week break.

Adverse reactions

Local reactions: possible hyperemia of the skin, slight pain or a burning sensation at the injection site.

Allergic reactions: rarely occur.

Contraindications

Hypersensitivity to Fibrovein components, acute thrombophlebitis, acute thrombosis, arterial insufficiency of the lower extremities, hemorrhagic diathesis, local and general infection.

Drug interactions

Pharmaceutical incompatible with heparin. It is not recommended to combine with oral contraceptives (especially anti-ovulatory).

Special instructions

1. Fibrovein should be used by doctors who are familiar with the sclerotherapy technique. It is necessary to properly evaluate valvular insufficiency and deep vein condition.
2. Vein sclerosis is carried out with caution with absolute confidence in the patency of the deep and communicative veins of the lower extremities.
3. Before starting treatment, it is necessary to know the patient's allergic history. You can enter the patient 0,25-0,5 ml of Fibrovein for 24 hours before the start of treatment to identify a possible allergic reaction.
4. Care must be taken when treating patients with peripheral atherosclerosis, Buerger's disease.
5. Especially carefully you need to enter the drug in the area above and behind the medial ankle, because there is a posterior tibial artery.
6. Do not allow extravasal (paravenous) and intraarterial administration.
7. Do not use the drug in case of precipitation or discoloration of the solution.
8. When the temperature in the solution decreases, a precipitate may form that dissolves when heated.
9. To prevent relapse after treatment, patients are recommended to wear elastic stockings.